Home> Meet us> HARMONY Alliance session at EHA2023

HARMONY Alliance session at EHA2023

Frankfurt, Germany

June 08, 2023 08:00 - June 11, 2023 - 20:00

HARMONY will participate in the EHA2022 Congress.

The Annual Congress of the European Hematology Association is organized from 8-11 June 2023 in Frankfurt, Germany.

Attendees can participate in person and virtual through live streaming. From 14-16 June 2023 the EHA2023 Thematic Days will take place all virtualEHA is a highly valued HARMONY and HARMONY PLUS Partner. 

Co-operative working groups, hospitals and academic institutions are invited to collaborate and contribute data to the HARMONY Alliance. Le'ts connect and explain more during EHA2023, please send us an email ito set up an appointment with HARMONY Experts, mail to communications@harmony-alliance.eu

You are invited to participate in the HARMONY Alliance session

Learn and interact about the impact of Real World Data and Real-World Evidence on research and clinical care now and in the future. Includes latest achievements of the HARMONY Alliance and plans for the future.

EHA2023 HARMONY Alliance abstracts

We are proud to present the following approved abstracts:

Click here to find the links to the abstract and details about the presentations on site >

EHA2023 HARMONY Alliance session

Date/time: Sunday, 11 June from 09:45-10:45 hrs | s238 | Hall Goldman

Our session is dedicated to the impact of Real-World Data and Real-World Evidence on research and clinical care, featuring:

View the full program here >

Meet us at the EHA2023 exhibition in booth F.117 and at the Collaboration Plaza.

After more than six years of joint work, the HARMONY Alliance reaped the benefits of building a research infrastructure with the best brains of European blood cancer research. Through a wide variety of collaborative activities, HARMONY has truly demonstrated the power of Big Data to improve the treatment of Hematologic Malignancies (HMs). In HARMONY research projects, scientists and physicians team up to produce novel insights into the biology of HMs. They run new algorithms and perform analyses on the thousands of anonymized data sets stored in the HARMONY Big Data Platform to detect relevant patterns. The results may be used to identify high-risk patients with greater reliability and to guide treatment choices in the future.

#bigdataforbloodcancer: Accelerating Better and Faster Treatment for Patients with Hematologic Malignancies.

#bigdataforbloodcancer: Accelerating Better and Faster Treatment for Patients with Hematologic Malignancies.

The HARMONY Alliance (HARMONY and HARMONY PLUS) is a public-private European Network of Excellence for Big Data in Hematology. Our mission is to unlock and spread valuable knowledge on hematologic malignancies (blood cancers) among a large number of stakeholders, with the goal to harness and mine Big Data to speed up the development of improved treatments for patients and more effective treatment strategies. HARMONY is a partnership with more than 140 organizations such as hospitals, research institutes, patient organizations, pharmaceutical companies, regulatory agencies, IT companies, and medical network and associations such as EHA. Together, they have developed the HARMONY Big Data Platform and the HARMONY Datalake, which contains anonymized data records from tens of thousands of blood cancer patients. This unique research infrastructure, with advanced big data analytic and AI tools, is being used to accelerate the development of more effective treatments for patients with hematologic malignancies (blood cancers).

HARMONY has identified more than 156,000 patient datasets and has transferred more than 73,000 datasets into the HARMONY Big Data Platform. Careful procedures have been installed to ensure the anonymization and quality of the data. In addition, HARMONY data scientists have developed sophisticated methods for data harmonization and analysis. Dedicated Research Project teams are currently using the Big Data Platform to answer critical research questions that cannot be addressed with other methods.


Receive the latest news. Click here to subscribe!